Skip to content
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact
  • Uncategorized

Conagra ‘GLP-1 Friendly’ Badge Taps the Weight Loss Drug Craze – Packaging Digest

Monday, March 3, 2025 – Select Healthy Choice frozen meal packages get a makeover with an "On Target" nutritional badge to target the 15.5 million US adults taking GLP-1 ...

  • Condie Carmack
  • March 3, 2025

Opinion: Are discount diet drugs safe? No one knows | The River Reporter

Monday, March 3, 2025 – ... compounded GLP-1 weight-loss drugs that are cheaper than the authentic prescription versions like Zepbound and Ozempic. These ads …

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Emergency Medicine Faculty Member Helping NASA to Solve the Problems of Medical Care …

Monday, March 3, 2025 – ... CU Researcher Studying Effects of GLP-1 Drugs on Alcohol Addiction. by Greg Glasgow | Feb 7, 2025 ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk – Drugs.com MedNews

Monday, March 3, 2025 – Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Trouble sleeping? The culprit may be something you ate – American Heart Association

Monday, March 3, 2025 – Among women, it altered levels of GLP-1, reducing satiety, meaning women felt less full after eating. So what foods should people eat if they want ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Hims & Hers Stock Dip and What It Means for Telehealth and Clinicians

Monday, March 3, 2025 – ... semaglutide shortage had been resolved. Semaglutide is the active ingredient in weight loss meds like Ozempic and Wegovy, and compounding is legal ...

  • Condie Carmack
  • March 3, 2025

AbbVie gets into obesity with $350M deal for once-weekly shot | BioPharma Dive

Monday, March 3, 2025 – If successful, these drugs could be used as alternatives to or in combination with marketed drugs like Novo's Wegovy and Lilly's Zepbound to increase ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

How to trick the body’s metabolism: Mouse study reveals new path for weight-loss and diabetes treatments

Monday, March 3, 2025 – Many people who have tried to lose weight by cutting calories are familiar with this frustrating reality: At some point, the body stops shedding pounds. It senses the reduced calorie intake and responds by slowing down metabolism, causing it to burn fewer calories than before the diet.

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Semaglutide: A Promising Treatment for Alcohol Use Disorder – INSCMagazine

Monday, March 3, 2025 – Semaglutide, a GLP-1 receptor agonist initially approved for type 2 diabetes and later for weight management, is now showing potential in treating ...

  • Condie Carmack
  • March 3, 2025
  • Uncategorized

Novo Nordisk Launches National “My Ozempic® Era” Campaign Celebrating Stories of …

Monday, March 3, 2025 – Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used: along with diet and exercise to improve blood ...

  • Condie Carmack
  • March 3, 2025
Prev
1 … 18 19 20 21 22 23 24 … 26
Next
© Copyright 2026 GenWeb of Texas